Traditional Chinese Medicine and Ayurveda  for Eye Disease:
What the Research Shows

Traditional Chinese Medicine (TCM) and Ayurveda are complete traditional medical systems, not single remedies. Both use individualized pattern assessment, diet and lifestyle guidance, body therapies and plant-based preparations. Both also contain concepts that do not map directly onto modern biomedical categories. The responsible question is not whether an entire tradition is “proven” or “disproven.” It is whether a specific intervention, product and clinical claim is supported for a specific eye condition - and whether it can be delivered safely alongside conventional care.

Traditional frameworks and modern ophthalmology ask different questions

Modern ophthalmology classifies disease by anatomy, imaging, genetics, physiology and clinical outcomes. TCM may describe patterns of deficiency, stagnation, heat or phlegm. Ayurveda may describe doshic imbalance, tissue nourishment and local ocular therapies. These traditional frameworks can guide individualized practice within their systems, but they should not replace biomedical diagnosis. A patient with acute angle closure, retinal detachment, giant-cell arteritis, infectious keratitis or retinal vascular occlusion needs emergency medical treatment, regardless of the traditional pattern.

At Netra Eye Institute, the safest integrative model is dual-language care: use modern diagnosis and objective testing to define the disease, then use traditional assessment to personalize supportive treatment without changing or delaying essential ophthalmic management.

What modern research is actually studying

Modern research studies whole herbal formulas, isolated natural compounds and traditional procedures. While these approaches may suggest antioxidant, anti-inflammatory, vascular or neuroprotective effects, they do not always establish which ingredient works, the correct dose or whether results apply safely to patients.

What the research does not establish

1. That an herb shown to protect cells in a laboratory will preserve vision in a human eye.
2. That one traditional formula treats every stage or subtype of glaucoma, AMD, diabetic retinopathy or retinal degeneration.
3. That a short-term change in acuity or circulation equals slower long-term structural progression.
4. That “natural” products are automatically safer than prescription medicine.
5. That a product sold under the same common name contains the same species, dose, contaminants or active compounds.
6. That an individualized formula can be assumed effective because one standardized product was studied.

Herbal safety is part of the treatment - not an afterthought

NCCIH warns that some Ayurvedic preparations may contain lead, mercury or arsenic, and that some Chinese herbal products have been contaminated with heavy metals, pesticides, microorganisms, undeclared drugs or the wrong herb. Traditional products can also cause liver injury, kidney injury, allergic reactions, blood-pressure changes, glucose changes or bleeding.
Ayurvedic preparations and Traditional products should be from reliable sources which monitors and tests for contaminations.

How Netra Restoration Therapy uses traditional medicine responsibly

Within NRT, TCM and Ayurvedic interventions are intended to be individualized according to diagnosis, systemic health, medications, constitution or pattern, and functional goals. The modern clinical rationale may include support for inflammatory regulation, oxidative balance, microcirculation, autonomic function, digestion, sleep, stress and metabolic health.

The program makes a clear claim boundary: traditional medicine may support the patient and may influence biological pathways, but it does not replace pressure control, anti-VEGF treatment, cross-linking, immunosuppression, surgery, genetic counseling or urgent ophthalmic care. Where condition-specific clinical evidence is weak, the website will say so.

A practical evidence-and-safety checklist

A practical safety checklist begins with clearly identifying the product or procedure, documenting all ingredients and doses, and reviewing possible interactions and medical risks. Products should come from traceable, tested suppliers, treatment goals should be measurable, and standard ophthalmic care should continue. Any new symptoms or abnormal findings should prompt treatment to stop and be investigated.

1. Name the exact product or procedure, not just “Ayurveda” or “Chinese medicine.”
2. Document every ingredient, species, part used, dose and duration.
3. Review prescription drugs, over-the-counter medicines and supplements for interactions.
4. Screen for pregnancy, allergies, liver or kidney disease, bleeding risk and autoimmune conditions.
5. Use suppliers with traceability and appropriate contaminant testing.
6. Define the intended outcome and how it will be measured.
7. Continue ophthalmic monitoring and established treatment.
8. Stop and investigate new symptoms or abnormal laboratory findings.

Frequently Asked Questions

Selected References for Scientific Support

• National Center for Complementary and Integrative Health. Ayurvedic Medicine: In Depth. Source
• National Center for Complementary and Integrative Health. Traditional Chinese Medicine: What You Need To Know. Source
• National Center for Complementary and Integrative Health. Herb-Drug Interactions. Source
• Li Y, et al. Traditional Chinese medicine approaches to age-related macular degeneration: a review. 2022. Source
• Jiawei Simiaoyongan granules in noninfectious anterior uveitis: randomized controlled study. 2026. Source